Data Handling and Reporting for Ongoing Clinical Trials During COVID-19
Featuring Nithiya Ananthakrishnan, Founder and CEO, Algorics
Complete the form to view this video
You may need to disable pop-up blocker
Abstract: ''Data Handling and Reporting for Ongoing Clinical Trials During COVID-19'
The COVID-19 outbreak has significantly impacted the clinical research industry. Analysis conducted on data obtained from www.clinicaltrials. gov on March 31, 2020, identified more than 9,250 industry-funded clinical trials that could be impacted. Regulatory agencies in the EU, US, and elsewhere have published guidance on how clinical trial sponsors could approach these ongoing studies. This presentation will specifically focus on how to handle data-related challenges from the statistical point of view, taking regulators' guidance into account.
About the speaker:
Nithiya Ananthakrishnan is the Founder & CEO of Algorics, a clinical data science company where he is responsible for company strategy and execution. Prior to Algorics, he held several leadership roles at ICON Clinical Research following time at Cognizant Technology Solutions. He actively participates and contributes to various industry consortium including DIA, SCDM, IASCT, Ph USE & PSI. He has been a proud recipient of PharmaVOICE 100 in 2017.